Alector, Inc. (ALEC)
NASDAQ: ALEC · Real-Time Price · USD
2.460
-0.050 (-1.99%)
At close: Sep 4, 2026, 4:00 PM EDT
2.450
-0.010 (-0.41%)
After-hours: Sep 4, 2026, 7:30 PM EDT
Alector Market Cap
Alector has a market cap or net worth of $274.68 million as of September 4, 2026. Its market cap has decreased by -2.73% in one year.
Market Cap
274.68M
Enterprise Value
134.64M
1-Year Change
-2.73%
Ranking
Category
Stock Price
$2.46
ChartMarket Cap Chart
Since February 7, 2019, Alector's market cap has decreased from $1.23B to $274.68M, a decrease of -77.68%. That is a compound annual growth rate of -17.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 274.68M | 61.31% |
| Dec 31, 2025 | 170.28M | -8.00% |
| Dec 31, 2024 | 185.09M | -72.43% |
| Dec 29, 2023 | 671.41M | -12.04% |
| Dec 30, 2022 | 763.34M | -54.52% |
| Dec 31, 2021 | 1.68B | 39.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 7, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vicore Pharma Holding AB | 313.67M |
| Pyxis Oncology | 312.78M |
| Foghorn Therapeutics | 307.02M |
| ProQR Therapeutics | 303.41M |
| Clinuvel Pharmaceuticals | 302.34M |
| Bicycle Therapeutics | 300.97M |
| Orchestra BioMed Holdings | 297.52M |
| Fulcrum Therapeutics | 293.74M |